Luskin Orthopaedic Institute Spreads Holiday Joy to 1,000 Children
Luskin Orthopaedic Institute Delivers Holiday Cheer to 1,000 Kids Luskin Orthopaedic Institute for Children (LuskinOIC) once again transformed its Downtown Los Angeles campus into a place of wonder, joy, and community as it welcomed more than 1,000 pediatric patients and…
Global Von Willebrand Disease Treatment Market Hits $1.75B by 2032
Global Von Willebrand Disease Treatment Market Poised for Strong Growth Through 2032, Driven by Biologic Innovation and Personalized Care ResearchAndMarkets.com has added the comprehensive report “Von Willebrand Disease Treatment Market – Global Forecast 2025–2032” to its expanding portfolio of healthcare…
Merck Agreement Aims to Lower Medicine Costs for Americans
Merck Announces Landmark Agreement With U.S. Government to Expand Affordable Access to Medicines and Strengthen Domestic Innovation Merck known as MSD outside the United States and Canada, has announced a landmark agreement with the U.S. government aimed at significantly expanding…
Global Women’s Digital Health Market Outlook, 2025–2032
Global Women’s Digital Health Market Forecast 2025–2032 Added to ResearchAndMarkets.com ResearchAndMarkets.com has announced the addition of its latest industry report, “Women’s Digital Health Market – Global Forecast 2025–2032,” offering an in-depth analysis of one of the fastest-growing segments within the…
Spinol Medical’s OctaSeal™ Enters FDA Review with 5-Year Clinical Data
Spinol Medical™ Advances OctaSeal™ Annular Closure System Into FDA Review, Introducing a Minimally Invasive Intradiscal Solution Supported by Five-Year Clinical Data Spinol Medical™ today announced that its OctaSeal™ Annular Closure System has advanced into formal review by the U.S. Food…
GE HealthCare, Indonesia Expand Access to Care with 300+ CT Scanners
Ge Health Care–indonesia Sihren Ct Scanner Expansion GE HealthCare to Deploy More Than 300 Advanced CT Scanners Across Indonesia Under Landmark SIHREN Program Indonesia GE HealthCare has announced a major, multi-year collaboration with Indonesia’s Ministry of Health to significantly expand…
HealthStream Adds Nation’s Largest Caregiver Network with Mission Care Collective Deal
HealthStream Expands Workforce Ecosystem with Acquisition of MissionCare Collective, Strengthening Caregiver Career Networks Nationwide HealthStream, a leading healthcare technology company specializing in workforce development solutions, today announced the acquisition of MissionCare Collective LLC (“MissionCare”), a healthcare workforce organization recognized for…
GenSci and RTW Partner on GS-098 for Graves’ and Thyroid Eye Disease
GenSci, RTW Investments, and Yarrow Bioscience Enter Strategic Global Partnership to Advance First-in-Class Anti-TSHR Antibody for Graves’ Disease and Thyroid Eye Disease SHANGHAI & NEW YORK Shanghai Scizeng Medical Technology Co LTD, a subsidiary of Changchun GeneScience Pharmaceutical (“GenSci”), together…
Washington Launches Tools for Life-Saving Opioid Medications
Washington State Expands Access to Life-Saving Medications for Opioid Use Disorder with New Provider Resource Library In a major step forward in Washington State’s ongoing response to the opioid crisis, the Washington State Health Care Authority (HCA) and the Department…
Aldeyra Reports PDUFA Extension for Dry Eye Drug Reproxalap
PDUFA Date Extended for Aldeyra’s Reproxalap Dry Eye NDA Aldeyra Therapeutics a biotechnology company focused on the discovery and development of innovative therapies for immune-mediated and inflammatory diseases, has announced that the U.S. Food and Drug Administration (FDA) has extended…
Natera and MEDSIR Announce Collaboration on MiRaDoR Breast Cancer Study
Natera and MEDSIR Partner on MiRaDoR Trial to Advance Genome-Guided Treatment Strategies in HR+/HER2- Breast Cancer Natera a global leader in cell-free DNA (cfDNA) testing and precision medicine, and MEDSIR (Medica Scientia Innovation Research), an international clinical research organization specializing…
FDA Clears NUZOLVENCE First Single-Dose Oral Treatment for Gonorrhea
Innoviva Specialty Therapeutics, a subsidiary of Innoviva, today announced that the U.S. Food and Drug Administration (FDA) has approved NUZOLVENCE (zoliflodacin) for oral suspension, a first-in-class, single-dose oral antibiotic for the treatment of uncomplicated urogenital gonorrhea in adults and adolescents…